Ghrelin

Also known as: Hunger Hormone, Lenomorelin, Growth Hormone Releasing Peptide

The hunger hormone produced in the stomach that regulates appetite and GI motility.

Overview

Ghrelin is a 28-amino acid peptide hormone primarily produced by cells in the stomach lining. Known as the 'hunger hormone,' it plays crucial roles in appetite regulation, gastric motility, and growth hormone release. It is being researched for gastroparesis and cachexia.

Mechanism of Action

Binds to growth hormone secretagogue receptor (GHSR) in hypothalamus to stimulate appetite. In the GI tract, it promotes gastric emptying and intestinal motility. Also stimulates growth hormone release from pituitary.

Pharmacokinetics

Short half-life of 10-30 minutes. Levels rise before meals and fall after eating. Acylation required for receptor binding.

Dosing Protocols

Note: These are research protocols from literature. This is not medical advice.

1

Gastroparesis Research

Dose

1-5 mcg/kg

Frequency

Before meals

Duration

Variable

Research protocols

2

Cachexia Research

Dose

2-5 mcg/kg

Frequency

1-2x daily

Duration

Weeks

Appetite stimulation

Stacking Recommendations

Peptides that may be combined based on complementary mechanisms in research settings.

Rationale: GI support

Synergy: Motility plus healing

Research Areas

GastroparesisCachexiaAnorexiaGI MotilityGrowth Hormone ReleaseAppetite Disorders

Key Research Findings

  • 1Accelerates gastric emptying in gastroparesis
  • 2Increases appetite and food intake
  • 3Improves nutritional status in cachexia
  • 4Stimulates GH release

Side Effects & Contraindications

Reported Side Effects

  • Increased appetite
  • Hunger
  • Mild glucose elevation

Contraindications

  • Diabetes (use caution)
  • Active GI bleeding

Safety Considerations

May increase appetite significantly. Blood glucose effects possible. Research compound for therapeutic use.

Storage Requirements

Store at -20C

Scientific References

Quick Reference

Sequence
Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg
Molecular Weight
3371 g/mol
Half-Life
10-30 minutes
Bioavailability
Injectable
Research Stage
clinical phase 2
Administration
Subcutaneous or IV